Chondrogenic Differentiation of Pluripotent Stem Cells under Controllable Serum-Free Conditions
Summary
The repair of damaged articular cartilage using currently available implantation techniques is not sufficient for the full recovery of patients. Pluripotent stem cells (iPSC)-based therapies could bring new perspectives in the treatment of joint diseases. A number of protocols of in vitro differentiation of iPSC in chondrocytes for regenerative purposes have been recently described. However, in order to use these cells in clinics, the elimination of animal serum and feeder cells is essential. In our study, a strictly defined and controllable protocol was designed for the differentiation of pluripotent stem cells (BG01V, ND 41658*H, GPCCi001-A) in chondrocyte-like cells in serum- and a feeder cell-free system, using the embryoid bodies step. The extension of the protocol and culture conditions (monolayer versus 3D culture) was also tested after the initial 21 days of chondrogenic differentiation. Promotion of the chondrogenic differentiation in 3D culture via the elevated expression of genes related to chondrogenesis was achieved. Using immunofluorescence and immunohistochemistry staining techniques, the increased deposition of the specific extracellular matrix was indicated. As a result, chondrocyte-like cells in the early stages of their differentiation using pellet culture under fully controlled and defined conditions were obtained.
| Authors | Lach MS, Wroblewska J, Kulcenty K, Richter M, Trzeciak T, Suchorska WM |
|---|---|
| Journal | International journal of molecular sciences |
| Publication Date | 2019 Jun 2;20(11) |
| PubMed | 31159483 |
| PubMed Central | PMC6600514 |
| DOI | 10.3390/ijms20112711 |